7917 Stock Overview
Provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
ZACROS Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,145.00 |
| 52 Week High | JP¥4,635.00 |
| 52 Week Low | JP¥3,580.00 |
| Beta | 0.55 |
| 11 Month Change | -3.49% |
| 3 Month Change | -4.71% |
| 1 Year Change | 6.56% |
| 33 Year Change | 11.57% |
| 5 Year Change | 17.76% |
| Change since IPO | 102.64% |
Recent News & Updates
Shareholder Returns
| 7917 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 0.5% | 0.08% | 0.2% |
| 1Y | 6.6% | 4.8% | 11.1% |
Return vs Industry: 7917 exceeded the JP Chemicals industry which returned 4.8% over the past year.
Return vs Market: 7917 underperformed the JP Market which returned 11.1% over the past year.
Price Volatility
| 7917 volatility | |
|---|---|
| 7917 Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 3.8% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.5% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 7917 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7917's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 2,664 | Taku Shimoda | www.zacros.co.jp |
ZACROS Corporation provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. It operates through four segments: Wellness Business, Environmental Solutions Business, Electronic Materials Business, and Industrial Infrastructure Business. The company offers wellness products, including BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; MediTect IV Bag, an infusion bags; and Total Thrombus formation Analysis System, a flow chamber system.
ZACROS Corporation Fundamentals Summary
| 7917 fundamental statistics | |
|---|---|
| Market cap | JP¥75.53b |
| Earnings (TTM) | JP¥4.70b |
| Revenue (TTM) | JP¥145.69b |
16.4x
P/E Ratio0.5x
P/S RatioIs 7917 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7917 income statement (TTM) | |
|---|---|
| Revenue | JP¥145.69b |
| Cost of Revenue | JP¥112.71b |
| Gross Profit | JP¥32.98b |
| Other Expenses | JP¥28.28b |
| Earnings | JP¥4.70b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 06, 2025
| Earnings per share (EPS) | 252.71 |
| Gross Margin | 22.64% |
| Net Profit Margin | 3.23% |
| Debt/Equity Ratio | 1.3% |
How did 7917 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield17%
Payout RatioDoes 7917 pay a reliable dividends?
See 7917 dividend history and benchmarks| ZACROS dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 63 days |
| Days until Dividend pay date | 3 days |
Does 7917 pay a reliable dividends?
See 7917 dividend history and benchmarks